BioSpace News Archive

Aidoc, the leading provider of healthcare AI solutions, today announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams.

Contraline, Inc. has appointed medical device industry leader Dr. Yelena Tropsha to the role of Chief Technology Officer.

VivoSense, Inc. today announced the close of a $25 Million Series A financing round.

Albany NY, United States: Plasma freezers are designed to maintain temperatures in the range of -30°C to -40°C.

VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts.

InnovHeart s.r.l. announced today the appointment of David James Wilson.

Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, is pleased to announce the acceptance of an abstract to be presented at the 2022 AACR Special Conference on Sarcomas.

Bluestar Genomics, Inc., today announced that its Chief Executive Officer David Mullarkey will participate in the Goldman Sachs fireside chat “The New Guard: Privates Leading The Disruption in Healthcare” on April 7, 2022 at 1:00 p.m., Eastern time.

Today, Virtualitics Inc, an advanced analytics and predictive AI company announced that the Institute for Systems Biology (ISB) will employ Virtualitics’ AI platform to enable researchers to discover the connections between vast amounts of Covid-related data for a research study on Long Covid treatment options.